Key Points
- Insider Laurel Yartz purchased 1,350 shares on Dec. 22 at an average price of $8.15, a $11,002.50 transaction that raised her stake by 9.33% to 15,826 shares (about $128,982).
- Shares opened at $8.86 and were trading up ~9.5%; the stock has a 12‑month range of $7.77–$27.28, a market cap of ~$86.9M and negative profitability (P/E -2.02, net margin -19.41%).
- Analyst sentiment is mixed with a consensus "Hold" and $16.50 target, while institutional investors own roughly 71.7% of the company.
Lakeland Industries, Inc. (NASDAQ:LAKE - Get Free Report) insider Laurel Yartz bought 1,350 shares of the company's stock in a transaction that occurred on Monday, December 22nd. The shares were bought at an average price of $8.15 per share, for a total transaction of $11,002.50. Following the transaction, the insider directly owned 15,826 shares in the company, valued at $128,981.90. This trade represents a 9.33% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website.
Lakeland Industries Trading Up 9.5%
NASDAQ:LAKE opened at $8.86 on Wednesday. Lakeland Industries, Inc. has a 12 month low of $7.77 and a 12 month high of $27.28. The company has a current ratio of 3.83, a quick ratio of 1.48 and a debt-to-equity ratio of 0.28. The stock has a market capitalization of $86.92 million, a price-to-earnings ratio of -2.02 and a beta of 1.33. The firm has a fifty day simple moving average of $14.23 and a two-hundred day simple moving average of $14.48.
Lakeland Industries (NASDAQ:LAKE - Get Free Report) last announced its quarterly earnings data on Wednesday, September 21st. The medical instruments supplier reported $0.36 earnings per share for the quarter. The firm had revenue of $27.47 million for the quarter. Lakeland Industries had a negative net margin of 19.41% and a negative return on equity of 7.80%. Analysts expect that Lakeland Industries, Inc. will post 0.48 EPS for the current fiscal year.
Lakeland Industries Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Monday, November 24th. Stockholders of record on Monday, November 17th were issued a dividend of $0.03 per share. The ex-dividend date was Monday, November 17th. This represents a $0.12 annualized dividend and a dividend yield of 1.4%. Lakeland Industries's payout ratio is currently -2.73%.
Hedge Funds Weigh In On Lakeland Industries
A number of large investors have recently made changes to their positions in LAKE. Royce & Associates LP raised its stake in shares of Lakeland Industries by 10.0% during the 3rd quarter. Royce & Associates LP now owns 1,178,670 shares of the medical instruments supplier's stock valued at $17,444,000 after purchasing an additional 107,100 shares during the period. Private Capital Management LLC grew its holdings in Lakeland Industries by 1.2% during the 3rd quarter. Private Capital Management LLC now owns 1,169,488 shares of the medical instruments supplier's stock valued at $17,308,000 after buying an additional 14,415 shares in the last quarter. Vanguard Group Inc. grew its holdings in Lakeland Industries by 2.3% during the 3rd quarter. Vanguard Group Inc. now owns 486,524 shares of the medical instruments supplier's stock valued at $7,201,000 after buying an additional 10,764 shares in the last quarter. First Eagle Investment Management LLC increased its position in shares of Lakeland Industries by 27.3% during the second quarter. First Eagle Investment Management LLC now owns 278,756 shares of the medical instruments supplier's stock valued at $3,794,000 after buying an additional 59,803 shares during the period. Finally, Ancora Advisors LLC lifted its holdings in shares of Lakeland Industries by 85.1% in the first quarter. Ancora Advisors LLC now owns 276,688 shares of the medical instruments supplier's stock worth $5,620,000 after buying an additional 127,195 shares in the last quarter. 71.69% of the stock is owned by institutional investors.
Analysts Set New Price Targets
LAKE has been the subject of a number of recent research reports. DA Davidson restated a "neutral" rating and set a $14.00 price target (down previously from $20.00) on shares of Lakeland Industries in a research note on Wednesday, December 10th. Roth Capital decreased their price objective on shares of Lakeland Industries from $27.00 to $19.00 and set a "buy" rating for the company in a research note on Wednesday, December 10th. UBS Group set a $14.00 target price on Lakeland Industries in a research note on Wednesday, December 10th. Wall Street Zen downgraded Lakeland Industries from a "hold" rating to a "strong sell" rating in a research report on Saturday, December 13th. Finally, Weiss Ratings reissued a "sell (d)" rating on shares of Lakeland Industries in a research report on Wednesday, October 8th. Two investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and two have issued a Sell rating to the company. According to MarketBeat.com, Lakeland Industries presently has a consensus rating of "Hold" and a consensus target price of $16.50.
View Our Latest Stock Report on LAKE
Lakeland Industries Company Profile
(
Get Free Report)
Lakeland Industries, Inc (NASDAQ:LAKE) is a global provider of high-performance protective apparel and accessories designed to safeguard workers in industrial, healthcare, laboratory, and emergency response environments. The company's expertise lies in producing garments that shield against chemical, biological, radiological, and thermal risks, supporting safety protocols in sectors such as oil and gas, petrochemicals, pharmaceuticals, and first responders.
The product portfolio encompasses both single-use and reusable solutions, including chemical protective coveralls, flame-resistant garments, arc flash clothing, medical isolation gowns, and cleanroom suits.
Further Reading

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].